FDA Person
FDAMarcellinus D. Dordunoo
View detailed information about Marcellinus D. Dordunoo, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Marcellinus D. Dordunoo, including their role, qualifications, and regulatory activities.
Recent Records (51)
Page 1 of 3483 - HV Pharmacy Inc. dba Hunt Valley PharmaLab
483
483 - Apex Pharmacy, LLC
483
483 - Emergent Manufacturing Operations Baltimore LLC.
483
483 - fusion iv pharmaceuticals, inc.
483
483 - fusion iv pharmaceuticals, inc.
483
483 - TERUMO YAMAGUCHI CORPORATION
483
483 - Eugia SEZ Private Limited
483
483 - Biocon Limited
483
MEMO - Jensen Farms
MEMO
OTHER_CORRESPONDENCE - Unknown Company
OTHER_CORRESPONDENCE
OTHER_CORRESPONDENCE - Blue Bell Creameries, L.P.
OTHER_CORRESPONDENCE
SAMPLE_RECORD - Jensen Farms
SAMPLE_RECORD
WARNING_LETTER_RESPONSE - Unknown Company
WARNING_LETTER_RESPONSE
STATE_REFERRAL_LETTER - Unknown Company
STATE_REFERRAL_LETTER
FDA_REQUESTED_RECALL_LETTER - Unknown Company
FDA_REQUESTED_RECALL_LETTER
INVESTIGATION_MEMO - Unknown Company
INVESTIGATION_MEMO
483 - fusion iv pharmaceuticals, inc.
483
483 - Sionc Pharmaceuticals Private Limited
483
483 - Syngene International Ltd.
483
483 - UBI Pharma, Inc.
483
Showing 1-20 of 51 records
Person Information
Name
Marcellinus D. Dordunoo
Title
Investigator
Role
Regulatory Personnel
ID: a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox